Discover 1,494 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
AbbVie
Location:
Code:
NCT04064827
Conditions
Chronic Kidney Disease (CKD)
Secondary Hyperparathyroidism (SHPT)
Eligibility Criteria
Sex: All
Age: 0 - 9
Healthy Volunteers: Not accepted
Interventions
Paricalcitol
Sponsor:
Edwards Lifesciences
Location:
Code:
NCT05172973
Conditions
Aortic Valve Insufficiency
Aortic Valve Stenosis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
SAPIEN X4 THV
Sponsor:
Takeda
Location:
Code:
NCT04844073
Conditions
Squamous Cell Cancer of Head and Neck (SCCHN)
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAK-186
Sponsor:
Seattle Urology Research Center
Location:
Code:
NCT00826527
Conditions
Urinary Frequency
Urinary Urgency
Nocturia
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Solifenacin PO
Sponsor:
ALX Oncology Inc.
Location:
Code:
NCT05002127
Conditions
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Evorpacept (ALX148)
Trastuzumab
Ramucirumab
Paclitaxel
Sponsor:
Gilead Sciences
Location:
Code:
NCT03547973
Conditions
Metastatic Urothelial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Govitecan-hziy
Pembrolizumab
Cisplatin
Avelumab
Zimberelimab
Sponsor:
Kowa Research Institute, Inc.
Location:
Code:
NCT05327127
Conditions
NASH
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
K-877-ER
CSG452
Placebo
Sponsor:
Intercytex
Location:
Code:
NCT00232973
Conditions
Leg Ulcer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ICXP007
Sponsor:
University of Washington
Location:
Code:
NCT04387227
Conditions
Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Pembrolizumab
Computed Tomography
Magnetic Resonance Imaging
Biospecimen Collection
Sponsor:
Viome
Location:
Code:
NCT05564273
Conditions
Metabolic Health
Eligibility Criteria
Sex: All
Age: 25 - 70+
Healthy Volunteers: Not accepted
Interventions
VIOME Precision Nutrition Program
VIOME-designed condition-based supplements
As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.
Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.
For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.
By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.
Seattle's reputation as a hub for clinical research is supported by its world-class research institutions and a collaborative healthcare community studying a wide range of medical conditions.
Seattle is a leader in cancer research, with institutions such as the Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance at the forefront. As the leading cause of death in the wider state of Washington, research here focuses on cutting-edge areas such as immunotherapy and personalized medicine.
Trials explore innovative treatments like CAR-T cell therapy, which modifies a patient’s own immune cells to target cancer, and novel drug combinations designed to overcome resistance to existing therapies. These efforts aim to improve survival rates and quality of life for cancer patients.
Seattle’s expertise in neurological research is reflected by institutions like the University of Washington’s Alzheimer’s Disease Research Center and the Allen Institute for Brain Science.
Clinical trials in this area delve into understanding the molecular and genetic underpinnings of neurodegenerative diseases. For instance, research on Alzheimer’s disease includes trials investigating potential disease-modifying drugs and advanced imaging techniques to detect early signs of cognitive decline. Similarly, studies on Parkinson’s disease and multiple sclerosis (MS) focus on new therapies that could slow disease progression or improve symptoms.
The city’s global health focus is evident in its research on infectious diseases. Institutions like the Fred Hutchinson Cancer Research Center and the University of Washington conduct trials on diseases such as HIV/AIDS, tuberculosis, and emerging pathogens like COVID-19.
Research here includes developing new vaccines, testing antiviral therapies, and exploring novel strategies for disease prevention and management. Seattle’s role in infectious disease research is bolstered by its commitment to global health and its response to emerging health threats.
Seattle’s research into autoimmune diseases such as rheumatoid arthritis, prurigo nodularis and lupus is conducted at leading institutions like the Fred Hutchinson Cancer Research Center and the University of Washington. Clinical trials explore new treatments aimed at modulating the immune system to reduce inflammation and damage associated with autoimmune conditions.
Clinical trials in Seattle also address metabolic disorders, including diabetes and obesity. The city’s research focuses on innovative approaches such as new medications, metabolic monitoring technologies, and lifestyle interventions designed to improve metabolic health. Studies investigate ways to better manage blood sugar levels, reduce obesity-related complications, and understand the metabolic pathways involved in these conditions.
Seattle’s research institutions, including the Swedish Medical Center and the University of Washington, are heavily involved in trials related to cardiovascular health. With heart disease being a leading cause of death in the state, these studies often focus on heart failure, coronary artery disease, and hypertension.
Current research includes evaluating the efficacy of new medications designed to manage heart failure, innovative interventional procedures such as catheter-based treatments, and lifestyle interventions aimed at preventing cardiovascular disease. Seattle’s emphasis on heart health is supported by its strong network of cardiologists and researchers dedicated to improving patient outcomes.
In Seattle, clinical trials are rigorously regulated by a combination of federal, state, and local guidelines, ensuring ethical and scientific integrity. Federal oversight is provided by the FDA, which enforces Good Clinical Practice (GCP) standards, and the Office for Human Research Protections (OHRP), which mandates Institutional Review Board (IRB) review and participant protection.
At the state level, the Washington State Department of Health oversees compliance with health regulations, while local IRBs provide additional scrutiny and oversight. Local research institutions and networks further uphold these standards, providing a well-regulated environment that supports innovative and responsible clinical research.
Participating in a clinical trial offers a unique chance to access cutting-edge treatments and therapies in the early stages of development and before they are widely available. Participants also benefit from exceptional care provided by top healthcare professionals, who ensure personalized attention and rigorous monitoring throughout the study.
Being involved in clinical trials is crucial for advancing medical research, often leading to significant progress in treatment and prevention for various conditions. By taking part, individuals not only access groundbreaking medical options early but also play a vital role in expanding scientific knowledge, ultimately improving healthcare outcomes for future patients.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: